U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Guirguis-Blake JM, Henderson JT, Perdue LA, et al. Screening for Gynecologic Conditions With Pelvic Examination: A Systematic Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Mar. (Evidence Syntheses, No. 147.)

Cover of Screening for Gynecologic Conditions With Pelvic Examination

Screening for Gynecologic Conditions With Pelvic Examination: A Systematic Review for the U.S. Preventive Services Task Force [Internet].

Show details

References

1.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol. 2009;114(6):1409-20. PMID: 20134296. [PubMed: 20134296]
2.
Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156(12):880-91, w312. PMID: 22711081. [PubMed: 22711081]
3.
Committee on Practice B-G. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstetrics & Gynecology. 2012;120(5):1222-38. PMID: 23090560. [PubMed: 23090560]
4.
Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health (Larchmt). 2011;20(1):5-10. PMID: 21194307. [PubMed: 21194307]
5.
Sawaya GF. Pelvic examinations in asymptomatic women: tipping a sacred cow. Arch Intern Med. 2011;171(22):2054-5. PMID: 22158577. [PubMed: 22158577]
6.
Sawaya GF, Jacoby V. Screening pelvic examinations: right, wrong, or rite? Ann Intern Med. 2014;161(1):78-9. PMID: 24979453. [PubMed: 24979453]
7.
Burns RB, Potter JE, Ricciotti HA, et al. Screening Pelvic Examinations in Adult Women: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center. Ann Intern Med. 2015;163(7):537-47. PMID: 26436618. [PubMed: 26436618]
8.
American College of Obstetricians and Gynecologists. Committee Opinion: Well-Woman Visit. http://www​.acog.org/Resources-And-Publications​/Committee-Opinions​/Committee-on-Gynecologic-Practice​/Well-Woman-Visit. Accessed 08/21/2014.
9.
Qaseem A, Humphrey LL, Harris R, et al. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(1):67-72. PMID: 24979451. [PubMed: 24979451]
10.
American College of Obstetricians and Gynecologists. ACOG Practice Advisory on Annual Pelvic Examination Recommendations. http://www​.acog.org/About-ACOG​/News-Room​/Practice-Advisories​/ACOG-Practice-Advisory-on-Annual-Pelvic-Examination-Recommendations. Accessed 11/05/2015.
11.
Sirovich BE, Welch HG. The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004;19(3):243-50. PMID: 15009779. [PMC free article: PMC1492158] [PubMed: 15009779]
12.
Stormo AR, Cooper CP, Hawkins NA, et al. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Preventive medicine. 2012;54(6):415-21. PMID: 22484240. [PubMed: 22484240]
13.
Henderson JT, Harper CC, Gutin S, et al. Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. American journal of obstetrics and gynecology. 2013;208(2):109.e1-7. PMID: 23159688. [PMC free article: PMC4350675] [PubMed: 23159688]
14.
Herman CR, Gill HK, Eng J, et al. Screening for preclinical disease: test and disease characteristics. AJR Am J Roentgenol. 2002;179(4):825-31. PMID: 12239019. [PubMed: 12239019]
15.
Herman C. What makes a screening exam “good”? The virtual mentor : VM. 2006;8(1):34-7. PMID: 23232314. [PubMed: 23232314]
16.
Buys SS, Partridge E, Greene MH, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193(5):1630-9. PMID: 16260202. [PubMed: 16260202]
17.
National Center for Health Statistics CfDCaP. National Ambulatory Medical Care Survey: 2012 Summary Tables. http://www​.cdc.gov/nchs​/data/ahcd/namcs_summary​/2012_namcs_web_tables.pdf. Accessed 07/28/2016.
18.
Medicare Learning Network CfMaMS, Department of Health and Human Services. Screening Pelvic Examinations. https://www​.cms.gov/Outreach-and-Education​/Medicare-Learning-Network-MLN​/MLNProducts​/Downloads/Screening-Pelvic-Examinations.pdf. Accessed 11/10/2015.
19.
American Academy of Family Physicians. Clinical Practice Guideline: Screening Pelvic Examination in Adult Women. http://www​.aafp.org/patient-care​/clinical-recommendations​/all​/screeningpelvicexam.html. Accessed 11/05/2015.
20.
Conry JA, Brown H. Well-Woman Task Force: Components of the Well-Woman Visit. Obstet Gynecol. 2015;126(4):697-701. PMID: 26348188. [PubMed: 26348188]
21.
Doroudi M, Kramer BS, Pinsky PF. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications. J Med Screen. 2016. PMID: 27903809. [PubMed: 27903809]
22.
Wallace BC, Small K, Brodley CE, et al. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium; Miami, Florida, USA. Writing: ACM; 2012. p. 819-24.
23.
United Nations Development Programme. 2014 Human Development Report. http://www​.undp.org/content​/undp/en/home​/presscenter/events/2014/july/HDR2014​.html. Accessed 04/13/2016.
24.
Wells GA, O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. http://www​.ohri.ca/programs​/clinical_epidemiology/oxford.asp. Accessed 11/09/2015.
25.
Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25. PMID: 14606960. [PMC free article: PMC305345] [PubMed: 14606960]
26.
Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36. PMID: 22007046. [PubMed: 22007046]
27.
Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21-35. PMID: 11306229. [PubMed: 11306229]
28.
Jacobs I, Stabile I, Bridges J, et al. Multimodal approach to screening for ovarian cancer. Lancet. 1988;1(8580):268-71. PMID: 2893084. [PubMed: 2893084]
29.
Adonakis GL, Paraskevaidis E, Tsiga S, et al. A combined approach for the early detection of ovarian cancer in asymptomatic women. European Journal of Obstetrics, Gynecology, & Reproductive Biology. 1996;65(2):221-5. PMID: 8730628. [PubMed: 8730628]
30.
Grover S, Quinn MA, Weideman P, et al. Screening for ovarian cancer using serum CA125 and vaginal examination: report on 2550 females. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1995;5(4):291-5. PMID: 11578492. [PubMed: 11578492]
31.
Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 Suppl):273S-309S. PMID: 11189684. [PubMed: 11189684]
32.
Gutman R, Peipert J, Weitzen S, et al. Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet Gynecol. 2005;105(3):551-6. PMID: 15738023. [PubMed: 15738023]
33.
Eschenbach DA, Hillier S, Critchlow C, et al. Diagnosis and clinical manifestations of bacterial vaginosis. American journal of obstetrics and gynecology. 1988;158(4):819-28. PMID: 3259075. [PubMed: 3259075]
34.
Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 1992;326(23):1533-9. PMID: 1315930. [PubMed: 1315930]
35.
Wolner-Hanssen P, Krieger J, Stevens C, et al. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989;261(4):571-6. PMID: 2783346. [PubMed: 2783346]
36.
Tiemstra JD, Pela E. Urinary symptoms after a routine pelvic exam. J Am Board Fam Med. 2011;24(3):290-5. PMID: 21551401. [PubMed: 21551401]
37.
Ebell MH, Culp M, Lastinger K, et al. A systematic review of the bimanual examination as a test for ovarian cancer. Am J Prev Med. 2015;48(3):350-6. PMID: 25595604. [PubMed: 25595604]
38.
Bloomfield HE, Olson A, Greer N, et al. Screening pelvic examinations in asymptomatic, average-risk adult women: an evidence report for a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(1):46-53. PMID: 24979449. [PubMed: 24979449]
39.
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012 Incidence and Mortality Web-based Report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute;2015. PMID: None.
40.
Hartge P, Hayes R, Reding D, et al. Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial. American journal of obstetrics and gynecology. 2000;183(5):1232-7. PMID: 11084571. [PubMed: 11084571]
41.
Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295-303. PMID: 21642681. [PubMed: 21642681]
42.
Padilla LA, Radosevich DM, Milad MP. Limitations of the pelvic examination for evaluation of the female pelvic organs. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2005;88(1):84-8. PMID: 15617719. [PubMed: 15617719]
43.
Padilla LA, Radosevich DM, Milad MP. Accuracy of the pelvic examination in detecting adnexal masses. Obstet Gynecol. 2000;96(4):593-8. PMID: 11004365. [PubMed: 11004365]
44.
Tayal VS, Crean CA, Norton HJ, et al. Prospective comparative trial of endovaginal sonographic bimanual examination versus traditional digital bimanual examination in nonpregnant women with lower abdominal pain with regard to body mass index classification. J Ultrasound Med. 2008;27(8):1171-7. PMID: 18645075. [PubMed: 18645075]
45.
Ueland FR, Depriest PD, Desimone CP, et al. The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol. 2005;99(2):400-3. PMID: 16084576. [PubMed: 16084576]
46.
Armstrong L, Zabel E, Beydoun H. Evaluation of the usefulness of the ‘hormones with optional pelvic exam’ programme offered at a family planning clinic. Eur J Contracept Reprod Health Care. 2012;17(4):307-13. PMID: 22524280. [PubMed: 22524280]
47.
Bourne P, Charles C, Francis C, et al. Perception, attitude and practices of women towards pelvic examination and Pap smear in Jamaica. N Am J Med Sci. 2010;2(10):478-86. PMID: 22558551. [PMC free article: PMC3339111] [PubMed: 22558551]
48.
Broadmore J, Carr-Gregg M, Hutton JD. Vaginal examinations: women's experiences and preferences. N Z Med J. 1986;99(794):8-10. PMID: 3456108. [PubMed: 3456108]
49.
Fiddes P, Scott A, Fletcher J, et al. Attitudes towards pelvic examination and chaperones: a questionnaire survey of patients and providers. Contraception. 2003;67(4):313-7. PMID: 12684154. [PubMed: 12684154]
50.
Golomb D. Attitudes toward pelvic examinations in two primary care settings. R I Med J. 1983;66(7):281-4. PMID: 6577533. [PubMed: 6577533]
51.
Haar E, Halitsky V, Stricker G. Patients' attitudes toward gynecologic examination and to gynecologists. Med Care. 1977;15(9):787-95. PMID: 895235. [PubMed: 895235]
52.
Harper C, Balistreri E, Boggess J, et al. Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam Plann Perspect. 2001;33(1):13-8. PMID: 11271540. [PubMed: 11271540]
53.
Hesselius I, Lisper H, Nordstrom A, et al. Comparison between participants and non-participants at a gynaecological mass screening. Scand J Soc Med. 1975;3(3):129-38. PMID: 1215854. [PubMed: 1215854]
54.
Hoyo C, Yamall K, Skinner C, et al. Pain predicts non-adherence to pap smear screening among middle-aged African American women. Preventive medicine. 2005;41(2):439-45. PMID: 15917039. [PubMed: 15917039]
55.
Osofsky H. Women's reactions to pelvic examination. Obstet Gynecol. 1967;30(1):146-51. PMID: 6027483. [PubMed: 6027483]
56.
Petravage JB, Reynolds LJ, Gardner HJ, et al. Attitudes of women toward the gynecologic examination. J Fam Pract. 1979;9(6):1039-45. PMID: 521765. [PubMed: 521765]
57.
Taylor V, Yasul Y, Burke N, et al. Pap testing adherence among Vietnamese American women. Cancer Epidemiol Biomarkers and Prev. 2004;13(4):613-9. PMID: 15066927. [PubMed: 15066927]
58.
Wijma B, Gullberg M, Kjessler B. Attitudes towards pelvic examination in a random sample of Swedish women. Acta Obstet Gynecol Scand. 1998;77(4):422-8. PMID: 9598951. [PubMed: 9598951]
59.
Yu C, Rymer J. Women's attitudes to and awareness of smear testing and cervical cancer. Br J Fam Plann. 1998;23(4):127-33. PMID: 9882766. [PubMed: 9882766]
60.
Kahn J, Goodman E, Huang B, et al. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic. Obstet Gynecol. 2003;101(3):490-9. PMID: 12636952 [PubMed: 12636952]
61.
Leeners B, Stiller R, Block E, et al. Effect of childhood sexual abuse on gynecologic care as an adult. Psychosomatics. 2007;48(5):385-93. PMID: 17878496. [PubMed: 17878496]
62.
Swahnberg K, Wijma B, Siwe K. Strong discomfort during vaginal examination: why consider a history of abuse? European journal of obstetrics, gynecology, and reproductive biology. 2011;157(2):200-5. PMID: 21470763. [PubMed: 21470763]
63.
Weitlauf JC, Finney JW, Ruzek JI, et al. Distress and pain during pelvic examinations: effect of sexual violence. Obstet Gynecol. 2008;112(6):1343-50. PMID: 19037045. [PubMed: 19037045]
64.
Weitlauf JC, Frayne SM, Finney JW, et al. Sexual violence, posttraumatic stress disorder, and the pelvic examination: how do beliefs about the safety, necessity, and utility of the examination influence patient experiences? J Womens Health (Larchmt). 2010;19(7):1271-80. PMID: 20509787. [PubMed: 20509787]
65.
Robohm JS, Buttenheim M. The gynecological care experience of adult survivors of childhood sexual abuse: a preliminary investigation. Women Health. 1996;24(3):59-75. PMID: 9046553. [PubMed: 9046553]
66.
Boyer SC, Pukall CF. Pelvic examination experiences in women with and without chronic pain during intercourse. J Sex Med. 2014;11(12):3035-50. PMID: 25243968. [PubMed: 25243968]
67.
Amy NK, Aalborg A, Lyons P, et al. Barriers to routine gynecological cancer screening for White and African-American obese women. Int J Obes (Lond). 2006;30(1):147-55. PMID: 16231037. [PubMed: 16231037]
68.
Saraiya M. Evidence is lacking to support pelvic examinations as a screening tool for non-cervical cancers or other conditions. Evid Based Med. 2015;20(1):31. PMID: 25260357. [PMC free article: PMC4516084] [PubMed: 25260357]
69.
Bump RC. “Pelvic: deferred”-have nongynecologists been right all along? American journal of obstetrics and gynecology. 2013;208(2):91. PMID: 23351727. [PubMed: 23351727]
70.
Bates C, Potter J. Screening pelvic examination in adult women. Ann Intern Med. 2014;161(12):925-6. PMID: 25506865. [PubMed: 25506865]
71.
Metz S, Gussman D. Screening pelvic examination in adult women. Ann Intern Med. 2014;161(12):925. PMID: 25506864. [PubMed: 25506864]
72.
Jennings JC, Blake J. Screening pelvic examinations in asymptomatic, average-risk adult women. Ann Intern Med. 2014;161(12):924. PMID: 25506862. [PubMed: 25506862]
73.
Oboler SK, Prochazka AV, Gonzales R, et al. Public expectations and attitudes for annual physical examinations and testing. Ann Intern Med. 2002;136(9):652-9. PMID: 11992300. [PubMed: 11992300]
74.
Prochazka AV, Lundahl K, Pearson W, et al. Support of evidence-based guidelines for the annual physical examination: a survey of primary care providers. Arch Intern Med. 2005;165(12):1347-52. PMID: 15983282. [PubMed: 15983282]
75.
Burns RB, Potter JE, Ricciotti HA, et al. Screening Pelvic Examinations in Adult Women: Grand Rounds Discussion From the Beth Israel Deaconess Medical CenterScreening Pelvic Examinations in Adult Women. Ann Intern Med. 2015;163(7):537-47. PMID: 26436618. [PubMed: 26436618]
76.
Committee on Health Care for Underserved Women. Committee opinion no. 615: Access to contraception. Obstet Gynecol. 2015;125(1):250-5. PMID: 25560140. [PubMed: 25560140]
77.
Gavin L, Moskosky S, Carter M, et al. Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep. 2014;63(Rr-04):1-54. PMID: 24759690. [PubMed: 24759690]
78.
Yu JM, Henderson JT, Harper CC, et al. Obstetrician-gynecologists' beliefs on the importance of pelvic examinations in assessing hormonal contraception eligibility. Contraception. 2014;90(6):612-4. PMID: 25108582. [PubMed: 25108582]
79.
Henderson JT, Sawaya GF, Blum M, et al. Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol. 2010;116(6):1257-64. PMID: 21099589. [PMC free article: PMC3745305] [PubMed: 21099589]
80.
Clancy CM, Massion CT. American women's health care. A patchwork quilt with gaps. JAMA. 1992;268(14):1918-20. PMID: 1404719. [PubMed: 1404719]
81.
Institute of Medicine. Clinical Preventive Services for Women: Closing the Gaps. Washington, D.C.: The National Academies Press; 2011. PMID: None
82.
Henderson JT, Weisman CS, Grason H. Are two doctors better than one? Women's physician use and appropriate care. Womens Health Issues. 2002;12(3):138-49. PMID: 12015186. [PubMed: 12015186]
83.
Henderson JT, Weisman CS. Women's patterns of provider use across the lifespan and satisfaction with primary care coordination and comprehensiveness. Med Care. 2005;43(8):826-33. PMID: 16034297. [PubMed: 16034297]
84.
Stormo AR, Saraiya M, Hing E, et al. Women's clinical preventive services in the United States: who is doing what? JAMA Intern Med. 2014;174(9):1512-4. PMID: 25003954. [PMC free article: PMC5833983] [PubMed: 25003954]
85.
Oei AL, Massuger LF, Bulten J, et al. Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer. 2006;94(6):814-9. PMID: 16495917. [PMC free article: PMC2361371] [PubMed: 16495917]
86.
Olivier RI, Lubsen-Brandsma MA, Verhoef S, et al. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol. 2006;100(1):20-6. PMID: 16188302. [PubMed: 16188302]
87.
van der Velde NM, Mourits MJ, Arts HJ, et al. Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer. 2009;124(4):919-23. PMID: 19035463. [PubMed: 19035463]
88.
Balbi GC, Musone R, Menditto A, et al. Women with a pelvic mass: indicators of malignancy. Eur J Gynaecol Oncol. 2001;22(6):459-62. PMID: 11874083. [PubMed: 11874083]
89.
van Nagell JR, Jr., Gallion HH, Pavlik EJ, et al. Ovarian cancer screening. Cancer. 1995;76(10 Suppl):2086-91. PMID: 8635005. [PubMed: 8635005]
90.
Kurjak A, Prka M, Arenas JM, et al. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women. Croat Med J. 2005;46(5):757-64. PMID: 16158468. [PubMed: 16158468]
91.
LeFevre ML. Screening for Chlamydia and Gonorrhea: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014. [PubMed: 25243785]
92.
National Cancer Institute. PDQ Endometrial Cancer Screening. http://cancer​.gov/cancertopics​/pdq/screening​/endometrial/HealthProfessional. Accessed 08/21/2014.
93.
American Cancer Society. Signs and symptoms of endometrial cancer. http://www​.cancer.org​/cancer/endometrialcancer​/detailedguide​/endometrial-uterine-cancer-signs-and-symptoms. Accessed 10/26/2015.
94.
National Cancer Institute. SEER Stat Fact Sheets: Ovary Cancer. http://seer​.cancer.gov​/statfacts/html/ovary.html. Accessed 08/21/2014.
95.
National Cancer Institute. PDQ Ovarian Cancer Screening. http://cancer​.gov/cancertopics​/pdq/screening​/ovarian/HealthProfessional. Accessed 08/21/2014.
96.
National Cancer Institute. PDQ Vaginal Cancer Treatment. http://www​.cancer.gov​/types/vaginal/patient​/vaginal-treatment-pdq.Accessed 10/26/2015.
97.
Centers for Disease Control and Prevention. Vaginal and Vulvar Cancers. http://www​.cdc.gov/cancer/vagvulv. Accessed 08/21/2014.
98.
National Cancer Institute. SEER Stat Fact Sheets: Vulvar Cancer. http://seer​.cancer.gov​/statfacts/html/vulva.html. Accessed 08/21/2014.
99.
Centers for Disease Control and Prevention. Bacterial Vaginosis - CDC Fact Sheet. http://www​.cdc.gov/std​/bv/STDFact-Bacterial-Vaginosis.htm. Accessed 09/03/2014.
100.
Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34(11):864-9. PMID: 17621244. [PubMed: 17621244]
101.
Centers for Disease Control and Prevention. Candidiasis Risk and Prevention. http://www​.cdc.gov/fungal​/diseases/candidiasis​/genital/risk-prevention.html. Accessed 09/03/2014.
102.
Sobel JD. UpToDate: Candida vulvovaginitis. http://www​.uptodate.com​/contents/candida-vulvovaginitis. Accessed 11/11/2015.
103.
Patel H, Wagner M, Singhal P, et al. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39. PMID: 23347441. [PMC free article: PMC3618302] [PubMed: 23347441]
104.
Centers for Disease Control and Prevention. Genital Herpes - CDC Fact Sheet (Detailed Version). http://www​.cdc.gov/std​/herpes/stdfact-herpes-detailed.htm. Accessed 08/21/2014.
105.
Bradley H, Markowitz LE, Gibson T, et al. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. The Journal of infectious diseases. 2014;209(3):325-33. PMID: 24136792. [PubMed: 24136792]
106.
Centers for Disease Control and Prevention. Pelvic Inflammatory Disease (PID) - CDC Fact Sheet. http://www​.cdc.gov/std/pid/STDFact-PID​.htm. Accessed 08/21/2014.
107.
Centers for Disease Control and Prevention. STDs in Women and Infants. 2014.
108.
Leichliter JS, Chandra A, Aral SO. Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive-aged women in the United States, 1995 and 2006-2010. Sex Transm Dis. 2013;40(5):413-8. PMID: 23588132. [PMC free article: PMC5245165] [PubMed: 23588132]
109.
Bohm MK, Newman L, Satterwhite CL, et al. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis. 2010;37(3):131-6. PMID: 20051931. [PubMed: 20051931]
110.
Centers for Disease Control and Prevention. Trichomoniasis - CDC Fact Sheet. http://www​.cdc.gov/std​/trichomonas/stdfact-trichomoniasis​.htm. Accessed 10/30/2014.
111.
Sobel JD. Trichomoniasis. UpToDate 2014.
112.
Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clinic proceedings. 2010;85(1):87-94. PMID: 20042564. [PMC free article: PMC2800285] [PubMed: 20042564]
113.
MedlinePlus. Cervical polyps. https://www​.nlm.nih.gov​/medlineplus/ency/article/001494.htm. Accessed 11/11/2015.
114.
Schenken RS. UpToDate: Pathogenesis, clinical features, and diagnosis of endometriosis. http://www​.uptodate.com​/contents/endometriosis-pathogenesis-clinical-features-and-diagnosis. Accessed 9/17/2014.
115.
Ballard KD, Seaman HE, de Vries CS, et al. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study--Part 1. BJOG : an international journal of obstetrics and gynaecology. 2008;115(11):1382-91. PMID: 18715240. [PubMed: 18715240]
116.
Greenlee RT, Kessel B, Williams CR, et al. Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial. American journal of obstetrics and gynecology. 2010;202(4):373.e1-9. PMID: 20096820. [PMC free article: PMC2847634] [PubMed: 20096820]
117.
Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123(1):141-8. PMID: 24463674. [PMC free article: PMC3970401] [PubMed: 24463674]
118.
Wu JM, Hundley AF, Fulton RG, et al. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278-83. PMID: 19935030. [PubMed: 19935030]
119.
Zimmermann A, Bernuit D, Gerlinger C, et al. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC women's health. 2012;12:6. PMID: 22448610. [PMC free article: PMC3342149] [PubMed: 22448610]
120.
Cooper SMA, S.J. UpToDate: Vulvar lichen sclerosus. http://www​.uptodate.com​/contents/vulvar-lichen-sclerosus. Accessed 01/11/2016.
121.
Practice Bulletin No. 149: Endometrial cancer.Obstet Gynecol. 2015;125(4):1006-26. PMID: 25798986. [PubMed: 25798986]
122.
Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin. 2001;51(1):38-75; quiz 7-80.PMID: 11577479. [PubMed: 11577479]
123.
Moyer VA Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157(12):900-4. PMID: 22964825. [PubMed: 22964825]
124.
American Academy of Family Physicians. Clinical Preventive Service Recommendation: Ovarian Cancer. http://www​.aafp.org/patient-care​/clinical-recommendations​/all/ovarian-cancer​.html. Accessed 11/09/2015.
125.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 2011;117(3):742-6. PMID: 21343791 [PubMed: 21343791]
126.
American Cancer Society. Ovarian Cancer: Can ovarian cancer be found early?http://www​.cancer.org​/cancer/ovariancancer​/detailedguide/ovarian-cancer-detection. Accessed 11/09/2015.
127.
American Cancer Society. Vulvar Cancer: Can vulvar cancer be found early?http://www​.cancer.org​/cancer/vulvarcancer​/detailedguide/vulvar-cancer-detection. Accessed 11/09/2015.
128.
U.S. Preventive Services Task Force. Screening for Genital Herpes. http://www​.uspreventiveservicestaskforce​.org/uspstf05/herpes/herpesrs.pdf. Accessed 09/03/2014.
129.
American Academy of Family Physicians. Clinical Preventive Service Recommendation: Genital Herpes Simplex Virus Infection. http://www​.aafp.org/patient-care​/clinical-recommendations​/all/genital-herpes​.html. Accessed 11/09/2015.
130.
U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(3):214-9. PMID: 18252683. [PubMed: 18252683]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (630K)

Other titles in these collections

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...